Showing results (71-80 of 97) with videos related to

Sort By:
Pageof 10
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 25, 2023
A VISION Substudy of Reader Agreement on 68Ga-PSMA-11 PET/CT Scan Interpretation to Determine Patient Eligibility for 177Lu-PSMA-617 Radioligand TherapyPhillip H Kuo, Don C Yoo, Ryan Avery, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 7, 2020
Optimal 68Ga-PSMA and 18F-PSMA PET window levelling for gross tumour volume delineation in primary prostate cancerCédric Draulans, Robin De Roover, Uulke A van der Heide, et al.
Cancer|July 20, 2024
Correlation analyses of radiographic progression-free survival with clinical and health-related quality of life outcomes in metastatic castration-resistant prostate cancer: Analysis of the phase 3 VISION trialMichael J Morris, Johann de Bono, James Nagarajah, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 20, 2022
Enhancing Radioiodine Incorporation into Radioiodine-Refractory Thyroid Cancer with MAPK Inhibition (ERRITI): A Single-Center Prospective Two-Arm StudyManuel Weber, David Kersting, Burkhard Riemann, et al.
Urologic Oncology|December 23, 2020
Clinical outcomes and molecular profiling of advanced metastatic castration-resistant prostate cancer patients treated with 225Ac-PSMA-617 targeted alpha-radiation therapyMaarten J van der Doelen, Niven Mehra, Inge M van Oort, et al.
Prostate Cancer and Prostatic Diseases|October 1, 2020
Evaluating F-18-PSMA-1007-PET in primary prostate cancer and comparing it to multi-parametric MRI and histopathologyBastiaan M Privé, Bas Israël, Melline G M Schilham, et al.
The Journal of Clinical Investigation|September 27, 2016
Sustained ERK inhibition maximizes responses of BrafV600E thyroid cancers to radioiodineJames Nagarajah, Mina Le, Jeffrey A Knauf, et al.
EJNMMI Research|July 15, 2025
The effect of androgen blockade on [68Ga]Ga-PSMA-11 and [18F]FDG PET uptake in patients with recurrent or metastatic salivary duct carcinoma: a prospective imaging studyNiels J van Ruitenbeek, Maike J M Uijen, Chantal M L Driessen, et al.
Cancer Discovery|October 12, 2018
EIF1AX and RAS Mutations Cooperate to Drive Thyroid Tumorigenesis through ATF4 and c-MYCGnana P Krishnamoorthy, Natalie R Davidson, Steven D Leach, et al.
Endocrine-Related Cancer|April 23, 2021
Co-inhibition of SMAD and MAPK signaling enhances 124I uptake in BRAF-mutant thyroid cancersKathleen A Luckett, Jennifer R Cracchiolo, Gnana P Krishnamoorthy, et al.
Pageof 10